Immunogenicity 14076
Sample ID
3926
Response
Negative
Tumor Type
Melanoma
Gene Symbol
TCEAL2
Transcript ID
uc022car.1
HLA INFO
C*06:02
TCR INFO
No TCR info found!
Full length protein sequence (227 aa)
MEKLF
1
NENEG
6
MPSNQ
11
GKIDN
16
EEQPP
21
HEGKP
26
EVACI
31
LEDKK
36
LENEG
41
NTENT
46
GKRVE
51
EPLKD
56
KEKPE
61
SAGKA
66
KGEGK
71
SERKG
76
KSEMQ
81
GGSKT
86
EGKPE
91
RGGRA
96
EGEGE
101
PDSER
106
EPESE
111
GEPES
116
ETRAA
121
GKRPA
126
EDDIP
131
RKAKR
136
KTNKG
141
LAQYL
146
KQYKE
151
AIHDM
156
NFSNE
161
DMIRE
166
FDNMA
171
RVEDK
176
RRKSK
181
QKLGA
186
FLWMQ
191
RNLQD
196
PFYPR
201
GPREF
206
RGGCR
211
APRRD
216
TEDIP
221
YV
226
Mutation Information
DNA mutation:
None
Peptide Range:
197 ~ 221
Mut AA position:
209 (13 in Wild Type peptide)
Alignment
Wild Type:
"NLQDPFYPRGPREFRGGCRAPRRDT
||||||||||||.||||||||||||
Mutant:
NLQDPFYPRGPRKFRGGCRAPRRDT"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) TCEAL2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay